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SUMMARY 
The aqueous and methanol extracts of three medicinal plants, Hugonia castaneifolia, Teclea nobilis and 
Turrae mombassana were evaluated for in vitro antiplasmodial activity against a chloroquine sensitive 
Plasmodium falciparum strain (D6) and in vivo, against a P. berghei ANKA strain in mice. The extracts were 
also assessed for cytotoxicity in Vero cell lines and acute toxicity in mice. The water extracts were 
moderately active with IC50 of 33.07 3g/ml for T. mombassana and 23.92 3g/ml for H. castaneifolia while the 
methanol extracts of T. mombassana, H. castaneifolia and T. nobilis were highly active in vitro with IC50 of 
6.1 3g/ml, 8.86 3g/ml and 8.61 3g/ml respectively. The methanol extract of T. mombassana had the highest 
chemosupppression followed by the methanol extract of H. castaneifolia in vivo. Aqueous extract of H. 
casteinofolia was weakly cytotoxic against Vero cells CC50 =22.00 3g/ml. No toxic effect or mortality was 
observed in mice treated orally with any of the extracts at the highest concentration of 5000mg/kg. These 
results demonstrate antimalarial potential and safety of the three medicinal plants tested, which are used 
traditionally for the treatment of malaria in Kenya.  
Keywords: Antiplasmodial; Malaria; Toxicity; Meliaceae; Rutaceae; Linaceae 
 
[Afr J Health Sci. 2012; 23:305315] 
 
 
   306 
African Journal of Health Sciences, Volume 23, Number 4, OctoberDecember 2012 
Introduction 
Chemotherapy of malaria worldwide is dependent on 
nine key drugs: chloroquine, amodiaquine  primaquine, 
mefloquine, quinine, sulfadoxine/pyrimethamine, 
pyrimethamine/dapsone,  halofantrine and artemisinin 
derivatives [1].  Unfortunately, most of these drugs 
have been rendered ineffective due to the continued 
spread of drug resistant P. falciparum strains. 
Sulfadoxine pyrimethamine, a combination antifolate 
drug, which was an inexpensive antimalarial has had 
unacceptable levels of therapeutic failure in many 
countries in Asia, South America and now Africa due 
to resistance [2]. This is also true for chloroquine, 
mefloquine and quinine, with several countries 
abandoning chloroquine as the firstline antimalarial 
drug. Artemisinins are currently the most effective drug 
against multidrug resistant strains of P. falciparum 
[35]. However, recent reports of high failure rates 
associated with artemisininbased combination 
therapy, as well as in vitro drugsusceptibility data, 
suggest the possibility of clinical artemisinin resistance 
along the Thai–Cambodian border [57]. 
Consequently, there is a pressing need for the 
development of new antimalarial drugs. 
The search for new drugs through the evaluation and 
validation of traditional medicines offers a good 
opportunity and a high credible channel for the 
discovery and development of better medicines. The 
advantage of such drugs is that their precursors are 
plants that are widely available in rural areas of Africa. 
In this study, extracts from three Kenyan medicinal 
plants, namely Hugonia castaneifolia, Teclea nobilis 
and Turraea mombassana were examined for their 
antimalarial activity and safety, in vitro and in mice. 
 
Materials and Methods 
Plant collection and preparation 
Plants were selected on the basis of their traditional 
reputation to treat fevers or malaria locally. The plants 
were collected in November 2008, around the vicinity 
of the Shimba Hills Game Reserve and adjoining part 
of Kinango division in Kwale District, Kenya. 
Permission for a sustainable plant harvesting was 
obtained from the Kenya Wildlife Services in the forest 
reserves, and from the local communities outside the 
forest area. A qualified and experienced taxonomist 
who was conversant with the flora of the area was part 
of the collection team. The plant specimens were 
identified and authenticated and voucher specimens 
deposited at the East African Herbarium, National 
Museum of Kenya.  The plant parts were airdried at 
room temperature under shade for 14 days and 
pulverized using a laboratory mill (Christy & Norris 
Ltd., Chelmsford, England) at the Center for Traditional 
Medicine and Drug Research, Kenya Medical 
Research Institute. The resulting powders were packed 
in air tight polythene bags, labeled and stored in the 
dark until used.  
Preparation of plant extracts. 
Each plant sample was separately extracted with water 
and methanol. For the methanol extracts 50 g of the 
powdered plant material was macerated with 500 ml of 
methanol at room temperature for 24 h, filtered through 
Whatman filter paper No. 1. The plant material was 
reextracted with 300 ml methanol for the same period 
and the filtrates pooled and concentrated under 
vacuum at 40 °C until dry. The concentrate was 
weighed and transferred to an air tight sample bottle 
and stored at 4 °C until used.  
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Another 50 g of the same sample was extracted once 
with 500 ml of distilled water in a water bath at 60 °C 
for 1 h, filtered and lyophilized in a freeze dryer. The 
dry extracts for all the samples similarly treated were 
weighed into airtight containers and stored at 4 °C until 
used. 
In vitro antiplasmodial testing 
The Sierra Leonean Chloroquine sensitive, 
Plasmodium falciparum strain (D6) was used in the 
study. The parasite cultures were donated by the 
Malaria Research and Reference Reagent Resource 
Center (MR4), Manassas, Virginia, USA. Parasite 
cultivation was carried out using previously described 
procedures [8,9]. Cultures were maintained in RPMI 
1640 culture medium (10.4 g/l) powdered medium 
without PABA and lactic acid (LA) dissolved in 960 ml 
of double distilled autoclaved water (DDAW), 
supplemented with 10% human serum, 25mM (5.94 
g/l) HEPES and 25mM NaHCO3. Human O+ red 
blood cells served as the parasites host cells. Test 
samples were prepared by dissolving in 100% 
Dimethyl sulfoxide (DMSO) and diluting in RPMI to 
lower the concentration of DMSO to ≤1%. Stock 
solution (1Lg/ml) of chloroquine was also prepared for 
use as the reference drug. Semiautomated micro 
dilution assay technique that measures the ability of 
the extracts to inhibit the incorporation of [G3H] 
hypoxanthine (Amersham International, 
Burkinghamshire, UK) into the malaria parasite was 
used in testing antiplasmodial activity [10]. Aliquots 
(50Ll) of the test solutions were added in the first wells 
of 96 well flat bottomed micro culture plates (Costar 
Glass Works, Cambridge, UK) in duplicate and serial 
diluted down the plate using a Titertek motorized hand 
diluter (Flow Laboratories, Uxbridge, UK). The last row 
of wells did not contain the test samples and served as 
the controls. Two hundred microliters of malaria 
parasite culture was added into each well. The set 
plates were incubated at 37 OC in a gas mixture 3% 
CO2, 5% O2 and 92% N2 for 48 h, after which each 
well was pulsed with 25Ll of culture medium containing 
0.5LCi of [G3H] hypoxanthine. The plates were 
incubated for a further 18 hours. The contents of each 
well were then harvested onto glass fiber filter mats, 
washed thoroughly with distilled water, dried and the 
radioactivity in counts per minute (cpm) measured 
using a betacounter (Wallac Micro Beta Trilux). The 
cpms obtained were then used to compute the IC50 
values as described by Sixsmith et al [11]. 
In vivo antimalarial testing 
Male Balb C mice (6–8 weeks old, weighing 20±2 g) 
were used in the experiment. The mice were housed 
in standard macrolon type II cages in airconditioned 
rooms at 22 OC, 50–70% relative humidity, fed with 
the standard diet and received water ad libitum. 
Plasmodium berghei strain ANKA was maintained by 
serial passage of infected blood through interperitonial 
injection (ip). The test protocol was based on the 4
day suppressive test [12]. Briefly, P. berghei infected 
blood was obtained by heart puncture, mixed with 1% 
(w/v) heparin in phosphate buffered saline (PBS) (1:1) 
and the test animals infected by ip injection with 0.2 
ml (1×107 parasitized erythrocytes). Infected mice were 
randomly selected into groups of five for one test 
sample and the experimental groups treated with a 
single dose of 800 mg/kg of the test sample in 0.2 ml 
by oral adminstration from day 0 (immediately after 
infection) to day 3 [13]. The mice in the positive 
control group were given chloroquine diphoshate 
(dissolved in 10% tween 80) at 5 mg/kg/day orally. 
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Those in the negative control group received the 
placebo (10% tween 80) at 0.2 ml/kg/day. 
Parasitaemia was determined on day 4 (24 h after the 
last treatment) by microscopic examination by counting 
parasites in 4 fields of ≈100 erythrocytes per view of 
thin blood film sampled from the tail of the 
experimental mouse and stained in 10% giemsa 
solution. The difference between the mean number of 
parasites per view in the negative control group 
(100%) and those of the experimental groups was 
calculated and expressed as percent parasitaemia 
suppression (chemo suppression) according to the 
formula: PS = [(A−B)/A]×100 [14]. Where, A is the 
mean parasitaemia in the negative control on day 4, 
and B the corresponding parasitaemia in the test 
group. The standard deviations for the mean values 
was calculated as described by Armitage and Berry 
[15]. All in vivo experiments were repeated three 
times. In cases where the standard deviation (SD) was 
large, the experiment was repeated yet again and in 
some instances, outliers were not considered while 
computing the SD. Percentage parasitaemia was 
described as number of parasitized erythrocytes per 
100 erythrocytes while percentage chemo suppression 
was taken as inhibition of parasite growth / 
multiplication relative to control expressed in 
percentage. Parasites in the negative control group 
were assumed to have experienced 0% chemo
suppression. Chemo suppression is thus the potency 
of the drug to inhibit parasite growth/multiplication. 
In vitro determination of cell cytotoxicity 
The Cytotoxic concentration causing 50% cell lysis and 
death (CC50) was determined for the extracts by a 
method described by Mosmann [16]. Vero E6 cells 
were seeded at a concentration of 2.5×104 cells/well 
in a 24 well plates and grown under 5% CO2 at 37 
OC 
in Eagle’s Minimum Essential Medium (MEM) 
supplemented with 5% fetal bovine serum (FBS) for 48 
hours. The culture medium was replaced by fresh 
medium containing a plant extract at various 
concentrations, and cells further grown for 24 hours. 
The cells were then treated with trypsin and the 
number of viable cells determined by the tryphan blue 
exclusion method. The concentration of herbal extract 
reducing cell viability by 50% (CC50) was determined 
from a curve relating percent cell viability to the 
concentration of extract. Selectivity index (SI = 
CC50/IC50) was used as a parameter of clinical 
significance of the test samples by comparing general 
toxins and selective inhibitory effect on Plasmodium 
falciparum [17].  
Determination of acute toxicity 
In vivo acute toxicity was determined in mice using 
standard procedures previously described [18, 19]. 
Male Swiss mice with a mean body weight of 20±2 g 
bred at the KEMRI experimental animal care facility in 
Nairobi, Kenya were used. They were randomly 
divided into groups of 5 mice, one group for each 
extract, plus one control group that was given Tween 
80. Each mouse was starved overnight prior to 
treatment. Increasing doses of the test extract (1000, 
2000, 3000, 4000, 5000 mg/kg/day) dissolved in 10% 
Tween 80 was administered orally, 30 minutes later 
the mice were allowed to take food. The general 
behavior of mice was observed continuously for 1 hour 
after the treatment, after 4 hours and thereafter over a 
period of 24 hours [20]. The mice were further 
observed daily for up to 14 days following treatment 
for any signs of toxicity.  
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Results 
Table 1 summarizes the plant species, voucher 
number, parts used and dry weights of the plants 
tested. The water extracts had a higher yield 
compared to their methanol counterparts. 
Table 1: Plant species, parts collected and yield of water and methanol extracts 
Botanical name Family  Voucher 
number 
Part used  Dry weight of extract% 
Water          methanol                    
Turraea mombassana C.DC Meliaceae Cm162 Leaves 6.5                        5 
Teclea nobilis Del. Rutaceae Cm153 Stem bark 5.9                       0.9        
Hugonia castaneifolia Engl. Linaceae Cm164 Twigs 4.3                       2.2 
 
In vitro anti?plasmodial assays 
Results of in vitro antiplasmodial and cytotoxicity 
assays are summarized in Table 2. Antiplasmodial 
activity was classified as follows: high at IC50 ≤10 
Lg/ml, moderate at 10–50 Lg/ml, low at 50–100 Lg/ml 
and inactive at >100 Lg/ml [21]. The methanol 
extracts were generally more active than those of the 
aqueous extracts. Methanol extracts of the three test 
plants T. mombassana, T. nobilis and H. castaneifolia 
were the most active against P. falciparum D6 strain in 
vitro with IC50 of ≤10 Lg/ml. The aqueous extracts, of 
T. mombassana  and H. casteinofolia exhibited 
moderate activity, while that of T. nobilis was inactive.  
 
Table 2: In vitro antiplasmodial activity (IC50 ±S.D.) of extracts of selected medicinal plants 
Plant  IC50 ± S.D. (µg/ml) 
Water  Methanol  
   
T. mombassana 33.07±1.42 6.104±0.86 
H. castaneifolia 23.92±1.08 8.86±1.87 
T. nobilis 130.5±9.4 8.61±1.37 
Chloroquine 0.0046 ± 1.8 
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In vivo antiplasmodial activity 
Results of in vivo antimalarial assay of the plant 
extracts against Plasmodium berghei in mice are 
summarized in Table 3. Suppression of parasitaemia 
(chemosuppression) in mice was used as a measure 
of efficacy. Chemosuppression of the test samples 
was categorized as high when it was above 70%, 
moderate between 50% and 69%, low between 30% 
and 49%,   inactive below 30% [2225]. The extracts 
exhibited significant parasite density reduction 
(p≤0.05) with chemosuppression ranging from 30.3% 
to 52.86%. Methanol extracts of T. mombassana and 
H. castaneiofolia were the most active with chemo
suppression of 52.86% and 46.76%, respectively. 
 
Table 3: In vivo antimalarial activity of selected medicinal plant extracts on Plasmodium berghei in mice 






T.  mombassana Methanol 17.88±1.87* 52.86±4.23 10.33±0.58 
H. castaneiofolia 
 
Methanol 18.23±4.83* 46.76±2.62 8.6±1.34  
Water 22.83±0.67* 36.6±3.12 9.0±2.61  
T. nobilis 
 
Methanol 23.84±0.81* 30.3±5.14 9.7±1.15  
Water 22.61±2.77* 33.9±3.71 9.25±1.25  




 0.34±0.03 98.46±0.12 16.33±5.7 
Results are expressed as means ± SD of 5 determinations per experiment.  
* = Value statistically significant p≤0.05 (test verses control by student t test).   
Mammalian toxicity assessment 
Results of the in vitro toxicity assessment are 
summarized in table 4. The aqueous extract of H. 
castaneifolia was moderately cytotoxic with CC50 of 22 
µg/ml. On the other hand the methanol extract of H. 
castaneifolia, aqueous or methanol extracts of T. 
mombassana  and T. nobilis were not cytotoxic even 
at 100 µg/ml, the highest concentration tested.  
In the acute toxicity assay, no deaths were observed 
at the highest concentration tested (5000 mg/kg) for 
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all the extracts. The mice treated with the plant 
extracts continued to gain weight at a similar rate to 
that seen in the untreated controls and no external 
toxic effects or mortality were observed within 14 days.  
 
Table 4: Cytotoxicity (CC50) of selected medicinal plants extracts on VERO cells 
Plant Extract Cytotoxicity activity     
CC50 (Lg/ml) 
Antiplasmodial 




T.  mombassana 
 
Water ≥100.00 33.07±1.42 N.C 
Methanol ≥100.00 6.104±0.86 N.C 
H. castaneifolia 
 
Water     22.00 23.92±1.08 0.92 
Methanol ≥100.00 8.86±1.87 N.C 
T. nobilis 
 
Water ≥100.00 130.5±9.4 N.C 
Methanol ≥100.00 8.61±1.37 N.C 
Control               Chloroquine 24.74 0.0046 ± 1.8 5378.26 
SI    =       CC50 / IC50 
N.C: Not Cytotoxic at the highest concentration tested. 
Discussion 
The aqueous extracts had lower antiplasmodial activity 
in vitro  compared with their corresponding methanol 
extracts. A possible explanation for the lower 
antiplasmodial activity observed in the aqueous 
extracts is that they were not prepared according to 
the traditional methods, in the traditional context, its 
very common for several plant taxa to be administered 
as mixtures or boiled in meat soup (water plus fat in 
the meat). In other cases, extraction is traditionally 
done by adding honey and letting it to ferment [25]. 
For this reason, it is possible that synergism could 
exist between the various phytochemicals or the 
different constituents could help extract and keep 
active lipophilic compounds in an aqueous solution in 
the traditional way of preparation [26]. This may 
explain why the methanolic extracts were more active, 
since methanol extracts have both polar and non polar 
compounds.    
In a previous study, Gakunju et al reported that the 
root water extract of T. mombassana had 
antiplasmodial activity with an IC50 of 90 Lg/ml against 
chloroquine sensitive P. falciparum strain (K67), while 
the water extract of the leaves of this plant, 
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investigated in the present study was found to have an 
IC50 of 33.07 Lg/ml against the chloroquine sensitive 
P. falciparum strain (D6), affirming antimalarial 
potential of this plant [27]. The knowledge that the 
leaves are more active than the roots is encouraging 
as harvesting of leaves for medicinal purposes is not 
destructive to the plants. Harvesting of the roots 
means uprooting the whole plant, hence destroying it. 
The water extract of Hugonia castaneifolia twigs, had 
good antimalarial activity, with no toxic signs in mice. 
However, the same extract showed cytotoxic activity 
on Vero E6 cell line in vitro. The isolation of a 
cytotoxic rosane diterpenoid hugorosenone from H. 
castaneifolia  root bark  has been reported [28]  
revealing that a similar compound could also be 
present in the twigs. In vitro cytotoxicity does not 
inevitably mean an extract cannot be used in humans 
[28,29] as there is potential for isolation of safe non 
toxic compound/s. For instance, Galega officinalis is a 
plant that has proved too toxic for widespread 
agricultural use, with the potential to induce tracheal 
frothing, pulmonary oedema, hydrothorax, hypotension, 
paralysis and even death in man and yet Metformin 
the current gold standard for management of type 2 
diabetes was isolated from it. Experimental and clinical 
evaluations of galegine, a substance produced by the 
herb G. officinalis provided the pharmacological and 
chemical basis for the subsequent discovery of 
metformin [30]. 
In the acute toxicity assay no deaths were observed at 
the highest concentration tested which was (5000 
mg/kg), indicating that the plant extracts were not 
toxic. Another pointer to the safety of most of the 
samples tested is that all the animals that received the 
extracts stayed alive for the entire period of the 4day 
suppressive test. Generally, if the test mice die before 
day 5, then the cause of death is usually attributed to 
the effect of the test drug rather than the parasites [31] 
suggesting that the therapeutic index is too low.  
Conclusion 
The activities observed both in vitro and in vivo as well 
as the safety studies for most of the plants selected, 
validate their use in traditional medicine to treat 
malaria. Out of the five extracts that had remarkable 
antiplasmodial activity in vitro, only the aqueous extract 
of H. castaneifolia was found to be cytotoxic. 
Intrestingly, it was not found to be toxic in mice. In 
view of this, it would be interesting to determine if the 
compounds responsible for the moderate cytotoxicity in 
H. castaneiofolia are the same or different from those 
responsible for in vitro antimalarial activity.  
Acknowledgements 
This work received financial support from 
UNICEF/UNDP/World Bank/WHO special programme 
for Research and Training in Tropical Diseases (TDR). 
We thank the Director, Centre for Biotechnology 
Research and Development at KEMRI for his support 
in this study and the Director, KEMRI for allowing 
publication of this work. 
 
References 
1. Willcox M, Bodeker G and Rasoanaivo P. 
(2004). Traditional Medicinal Plants and 
Malaria. CRC Press,Washington D.C. 2004. 
 
   313 
African Journal of Health Sciences, Volume 23, Number 4, OctoberDecember 2012 
2. Plowe CV. Monitoring antimalarial drug 
resistance: making the most of the tools at 
hand. Journal of Experimental Biology. 2003; 
206: 3745–3752. 
3. Katuura E, Waako P, Tabuti JRS, Bukenya
Ziraba R, and Okeng OJ. Antiplasmodial 
activity of extracts of selected medicinal plants 
used by local communities in western Uganda 
for treatment of malaria. African Journal of 
Ecology. 2007; 45: 94–98. 
4. Dianne J, Jeanne M, Margarette S, Oren S, 
Aggrey J, Piet A, Altaf A, Bernard L and Feiko 
O. Treatment history and treatment dose are 
important determinants of sulfadoxine
pyrimethamine efficacy in children with 
uncomplicated malaria in Western Kenya. 
Journal of Infectious Diseases. 2003; 187: 
467468. 
5. Wongsrichanalai C and Meshnick RS. 
Declining ArtesunateMefloquine efficacy 
against Falciparum Malaria on the Cambodia–
Thailand Border. Journal of Emerging 
Infectious Diseases. 2008; 14: 7169. 
6. Jambou R, Legrand E and Niang M. 
Resistance of Plasmodium falciparum   field 
isolates to invitro artemether and point 
mutations of the SERCAtype PfATPase6. 
Lancet. 2005; 366: 19603. 
7. Vijaykadga S, Rojanawatsirivej C, Cholpol S, 
Phoungmanee D, Nakavej A and 
Wongsrichanalai C. In vivo sensitivity 
monitoring of mefloquine monotherapy and 
artesunatemefloquine combinations for the 
treatment of uncomplicated falciparum malaria 
in Thailand in 2003. Tropical Medicine and 
International Health. 2006; 11: 2119. 
8. Trager W. and Jensen J. B. Human malaria 
parasites in continuous culture. Science. 1976; 
193: 673675. 
9. Schlichtherle, M., Wahlgren, M., Perlmann, H. 
and Scherf, A. Methods in Malaria Research. 
MR4/ATCC, Manassas, Virginia. 2000; 174. 
10. Desjardins RE, Canfield C, Haynes J and 
Chulay J. Quantitative assessment of anti
malarial activity in vitro by a semiautomated 
microdilution technique. Antimicrobial Agents 
and Chemotherapy. 1979; 16: 710718. 
11. Sixsmith DG, Watkins WM, Chulay JD and 
Spencer HC. In vitro antimalarial activity of 
tetrahydrofoliate dehydrogenase inhibitors. 
American Journal of Tropical Medicine and 
Hygiene. 1984; 33: 772776. 
12. Peters W, Portus JH and Robinson BL. The 
chemotherapy of rodent malaria, XXII. The 
value of drug resistant strains of Plasmodium 
berghei in screening for blood schizontocidal 
activity. Annals of Tropical Medicine and 
Parasitology 1975; 69: 155171. 
13. Gessler M C, Tanner M, Chollet J, Nkunya 
MHH and  Heinrick M. Tanzanian medicinal 
plants used traditionally for the treatment of 
malaria: in vivo antimalarial and in vitro 
cytotoxic activities. Phytotherapy Research. 
1995; 9: 504–508. 
 
   314 
African Journal of Health Sciences, Volume 23, Number 4, OctoberDecember 2012 
14. Tona L, Mesia K, Ngimbi NP, Chrimwami B, 
Cimanga OK, De Bruyne T, Pieters L and 
Vlietinck AJ. Invivo antimalarial activity of 
Cassia    occidentalis, Morinda morindoides 
and phyllanthus niruri. Annals of Tropical 
Medicine and Parasitology. 2001; 95: 47–57. 
15. Armitage P and Berry G. Statistical Methods in 
Medicinal Research. Blackwell Science Ltd, 
Oxford, UK, 1991; 90–92. 
16. Mossman T. Rapid colorimetric assay for 
cellular growth and survival: Application to 
proliferation and cytotoxicity assays. Journal of 
Immunological Methods. 1983; 65: 5563. 
17. Phillipson  J D  and Wright  C W. Can 
ethnopharmacology contribute to the 
development of antimalarial agents? Journal 
of Ethnopharmacology. . 1991; 32: 155–165. 
18. Lorke D. A new approach to practical acute 
toxicity testing. Archives of Toxicology. 1983; 
54: 275287. 
19. WHO/EDM/TRM/2000.1. General guidelines 
for methodologies on research and evaluation 
of traditional medicines. WHO, Geneva, 2000. 
20. Twaij HAA, Kery A and Al Khazraji NK. Some 
pharmacological, toxicological and 
phytochemical investigations on Centaurea 
phyllocephala. Journal of Ethnopharmacology. 
1983; 9: 299–314. 
21. Gathirwa JW, Rukunga G M, Njagi ENM, Omar 
SA, Guantai AN, Muthaura CN, Mwitari PG, 
Kimani CW, Kirira PG, Tolo FM., Ndunda TN 
and Ndiege IO. In vitro antiplasmodial and in 
vivo antimalarial activity of some plants used in 
the treatment of malaria by the Meru 
community in Kenya. Journal of Natural 
Medicines. 2007; 61: 261–268. 
22. Muregi FW, Ishih A, Miyase T, Suzuki T, Kino 
H, Amano T, Mkoji GM and Terada M. 
Antimalarial activity of methanolic extracts from 
plants used in Kenyan ethnomedicine and their 
interactions with chloroquine (CQ) against a 
CQtolerant rodent parasite, in mice. Journal 
of Ethnopharmacology. 2007; 111: 90–195. 
23. Carvalho LH, Brandão MGL, SantosFilho D, 
Lopes JLC and Krettli AU. Antimalarial activity 
of crude extracts from Brazilian plants studied 
in vivo in Plasmodium bergheiinfected mice 
and in vitro against Plasmodium falciparum in 
culture. Brazilian Journal of Medical and 
Biological Research. 1991; 24: 1113– 1123. 
24. AndradeNeto VF, Brandão MGL, Stehmann 
JR, Oliveira LA and Krettli AU.  Antimalarial 
activity of Cinchonalike plants used to treat 
fever and malaria in Brazil. Journal of 
Ethnopharmacology. 2003; 87: 253–256. 
25. Gathirwa JW, Rukunga GM, Mwitari PG, 
Mwikwabe MN,  Muthaura CN, Kimani CW, 
Kiboi DM, Nyangacha RM and Omar SA. 
Traditional herbal antimalarial therapy in Kilifi 
district, Kenya. Journal of Ethnopharmacology. 
2011; 134: 434–442. 
26. Clarkson C, Maharaj VJ, Crouch NR, Grace 
OM, Pillay P, Matsabisa MG, Bhagwandhin N, 
Smith PJ and Folb PI. In vitro antiplasmodial 
 
   315 
African Journal of Health Sciences, Volume 23, Number 4, OctoberDecember 2012 
activity of medicinal plants native to or 
naturalized in South Africa. Journal of 
Ethnopharmacology 2004. 92: 177191. 
27. Gakunju DMN, Mberu IEK, Dossaji SF, Gray 
AI, Waigh R D, Waterman PG and Watkins 
WM. Potent antimalarial activity of the alkaloid 
nitidine, isolated from a Kenyan herbal 
remedy. Antimicrobial Agents and 
Chemotherapy. 1995; 39: 26062609. 
28. Baraza DL, Cosam C, Joseph CC, Joan JE, 
Munissi JEJ, Nkunya HHM, Arnold N, Porzel, A 
and Wessjohann L. Antifungal rosane 
diterpenes and other constituents of Hugonia 
castaneifolia . Phytochemistry. 2008; 69: 
200205. 
29. Kokwaro JO. Medicinal Plants of East Africa. 
Kenya Literature Bureau, Nairobi, 1993. 
30. Bailey CJ, Campbell IW, Chan JCN, Davidson 
JA, Howlett HCS and Ritz P. Metformin: the 
Gold Standard. A Scientific handbook. 
Chichester, Wiley, 2007. 
31. Jutamaad S, Noppamas S, Aimon S and 
Yodhathai T. Toxicological and antimalarial 
activity of eurycomalactone and Eurycoma 
longifolia Jack extract in mice. Thai Journal of 
Phytopharmacy. 1998; 5: 14–17. 
 
 
 
 
